Assessing the public health risk of Shiga toxin-producing Escherichia coli by use of a rapid diagnostic screening algorithm.
Shiga toxin-producing Escherichia coli (STEC) is an enteropathogen of public health concern because of its ability to cause serious illness and outbreaks. In this prospective study, a diagnostic screening algorithm to categorize STEC infections into risk groups was evaluated. The algorithm consists of prescreening stool specimens with real-time PCR (qPCR) for the presence of stx genes. The qPCR-positive stool samples were cultured in enrichment broth and again screened for stx genes and additional virulence factors (escV, aggR, aat, bfpA) and O serogroups (O26, O103, O104, O111, O121, O145, O157). Also, PCR-guided culture was performed with sorbitol MacConkey agar (SMAC) and CHROMagar STEC medium. The presence of virulence factors and O serogroups was used for presumptive pathotype (PT) categorization in four PT groups. The potential risk for severe disease was categorized from high risk for PT group I to low risk for PT group III, whereas PT group IV consists of unconfirmed stx qPCR-positive samples. In total, 5,022 stool samples of patients with gastrointestinal symptoms were included. The qPCR detected stx genes in 1.8% of samples. Extensive screening for virulence factors and O serogroups was performed on 73 samples. After enrichment, the presence of stx genes was confirmed in 65 samples (89%). By culture on selective media, STEC was isolated in 36% (26/73 samples). Threshold cycle (CT) values for stx genes were significantly lower after enrichment compared to direct qPCR (P < 0.001). In total, 11 (15%), 19 (26%), 35 (48%), and 8 (11%) samples were categorized into PT groups I, II, III, and IV, respectively. Several virulence factors (stx2, stx2a, stx2f, toxB, eae, efa1, cif, espA, tccP, espP, nleA and/or nleB, tir cluster) were associated with PT groups I and II, while others (stx1, eaaA, mch cluster, ireA) were associated with PT group III. Furthermore, the number of virulence factors differed between PT groups (analysis of variance, P < 0.0001). In conclusion, a diagnostic algorithm enables fast discrimination of STEC infections associated with a high to moderate risk for severe disease (PT groups I and II) from less-virulent STEC (PT group III).
Department of Research and Development, Certe Laboratory for Infectious Diseases, Groningen, the Netherlands Department of Medical Microbiology, Certe Laboratory for Infectious Diseases, Groningen, the Netherlands r.deboer@certe.nl.
Richard F
RF
de Boer
Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Mithila
M
Ferdous
Department of Medical Microbiology, Certe Laboratory for Infectious Diseases, Groningen, the Netherlands Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Alewijn
A
Ott
Department of Medical Microbiology, Certe Laboratory for Infectious Diseases, Groningen, the Netherlands.
Henk R
HR
Scheper
Department of Research and Development, Certe Laboratory for Infectious Diseases, Groningen, the Netherlands.
Guido J
GJ
Wisselink
Center of Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Max E
ME
Heck
Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
John W
JW
Rossen
Department of Research and Development, Certe Laboratory for Infectious Diseases, Groningen, the Netherlands Department of Medical Microbiology, Certe Laboratory for Infectious Diseases, Groningen, the Netherlands Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Anna M D
AM
Kooistra-Smid
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000465:Algorithms; D001431:Bacteriological Techniques / Q000379:methods*; D002648:Child; D002675:Child, Preschool; D003470:Culture Media / Q000737:chemistry; D004927:Escherichia coli Infections / Q000453:epidemiology* / Q000382:microbiology*; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D019081:O Antigens / Q000032:analysis; D011446:Prospective Studies; D060888:Real-Time Polymerase Chain Reaction / Q000379:methods; D018570:Risk Assessment; D012703:Serotyping / Q000379:methods; D054323:Shiga-Toxigenic Escherichia coli / Q000145:classification / Q000302:isolation & purification*; D013997:Time Factors; D037521:Virulence Factors / Q000235:genetics; D055815:Young Adult
D003470:Culture Media; D019081:O Antigens; D037521:Virulence Factors